Lakefront Biotherapeutics (LKFT) Return on Sales (2014 - 2026)

Lakefront Biotherapeutics (LKFT) has 13 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales climbed to 0.0% in Q1 2026 per LKFT's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q1 2024 and troughed at 0.0% in Q3 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2023 and 2025: Return on Sales rose 1 bps in 2023, then decreased 1 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then dropped by 3 bps to 0.0% in 2023, then plunged by 55 bps to 0.0% in 2024, then plunged by 100 bps to 0.0% in 2025, then jumped by 24657 bps to 0.0% in 2026.
• Business Quant data shows LKFT's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.